28 Nov 2012, BioSpectrum Bureau , BioSpectrum
Singapore: Mr Xu Hang has resigned from the position of co-chief executive officer (co-CEO) at Mindray Medical International. Mr Xu Hang will, however, remain the company's chairman. Mr Li Xiting, Mindray's president and co-CEO, was appointed CEO by the company's board of directors following Mr Xu Hang's resignation. He will also continue to serve as the president.
Mindray Medical International, a leading developer, manufacturer and marketer of medical devices worldwide, made the announcements on November 5, 2012.
A key founding member of Mindray, Mr Li Xiting has served as the company's director, president and co-CEO since 1991. He will continue to oversee Mindray's business operations and overall management. Mr Li received his bachelor's degree from the University of Science and Technology of China.
"The board and I believe that separating the roles of chairman and CEO will strengthen the company's corporate governance, a necessary new structure to support Mindray's long-term prosperity," Mr Xu Hang commented. "I am very pleased that Mr Li will continue to lead the company. I strongly believe that under his leadership, Mindray will execute its strategies successfully and be able to further accelerate its growth and expansion."
"Since Mindray's inception 21 years ago, Mr Xu's outstanding vision and dedication have been instrumental to our success and to our transformation from a local Chinese medical device company to a publicly traded, internationally recognized corporation. We want to thank him for his significant contributions to the organization," Mr Li commented. "I am very pleased that he will remain as our chairman and help our company make strategic decisions in the future. I am also much honored to be appointed as Mindray's president and CEO and look forward to continuing to lead the company to the next level."